| DEXCOM INC. DL-,001 |
| USA |
| Gesundheit |
| US2521311074 / A0D9T1 |
| DC4 (Frankfurt) / DXCM (NASDAQ) |
| FRA:DC4, ETR:DC4, DC4:GR, NASDAQ:DXCM |
| https://www.dexcom.com/ |
|
DexCom, Inc. is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its primary products deliver real-time glucose readings through small, wearable sensors that provide accurate, p..
>Volltext.. |
| 23727.74 Mio. EUR |
| 22835.51 Mio. EUR |
| 4146.95 Mio. EUR |
| 1112.33 Mio. EUR |
| 800.83 Mio. EUR |
| 2.06 EUR |
| 1191.95 Mio. EUR |
| 962.48 Mio. EUR |
| - |
| 1.09 |
| 8.76% |
| 62.78% |
| - |
| - |
| - |
| DEXCOM |
| 22.05.26 |
|
||||
|